0
0
12/5/23 at 11:32pm
Organization
CNBCTV18
Author
Hormaz Fatakia
27 words
0
Comments
The agreement includes an upfront payment of $15 milion, regulatory and commercial milestones and royalties.
You are the first to view
https://www.cnbctv18.com/market/sun-pharma-share-price-subsidiary-signs-licensing-agreement-aclaris-alopecia-treatment-deuruxolitinib-18498741.htm
Create an account
or login to join the discussion